Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials

• Main Authors: Pierce D (Author), Corcoran M (Author), Martin P (Author), Barrett K (Author), Inglis S (Author), Preston P (Author), Thompson TN (Author), Willsie SK (Author)
• Format: Book
• Published: Dove Medical Press, 2014-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

David Pierce,1 Mary Corcoran,2 Patrick Martin,2 Karen Barrett,1 Susi Inglis,1 Peter Preston,2 Thomas N Thompson,3 Sandra K Willsie3 1Shire, Basingstoke, UK; 2Shire, Wayne, PA, USA; 3PRA International, Lenexa, KS, USA Background: MMX® mesalamine is a once daily oral 5-aminosalicylic acid form...